Goldman Sachs Group Inc Meridian Bioscience Inc Transaction History

Goldman Sachs Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 14, 2024	BUY	$31.15 - $33.39 $2.59 Million - $2.77 Million	83,046 Added 8.53%	1,056,680 $35.1 Million
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $2.59 Million - $2.77 Million	83,046 Added 8.53%	1,056,680 $35.1 Million
Q3 2022 May 14, 2024	BUY	$30.9 - $33.55 $23 Million - $25 Million	745,570 Added 326.91%	973,634 $30.7 Million
Q3 2022 Nov 10, 2022	BUY	$30.9 - $33.55 $23 Million - $25 Million	745,570 Added 326.91%	973,634 $30.7 Million
Q2 2022 May 14, 2024	BUY	$23.75 - $31.69 $5.42 Million - $7.23 Million	228,064 New	228,064 $6.94 Million
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $443,080 - $591,208	18,656 Added 8.91%	228,064 $6.94 Million
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $190,653 - $257,196	-9,547 Reduced 4.36%	209,408 $5.44 Million
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $123,075 - $152,328	-7,049 Reduced 3.12%	218,955 $4.47 Million
Q3 2021 Nov 10, 2021	BUY	$17.35 - $22.5 $3.92 Million - $5.09 Million	226,004 New	226,004 $4.35 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.